These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 950583)

  • 1. [Proposal for specifications concerning the study of dispersed systems (powders, suspensions...) very fine, extra-fine, ultrafine and micro-fine].
    Mayné F; Guyot JC; Traisnel M
    J Pharm Belg; 1976; 31(2):181-90. PubMed ID: 950583
    [No Abstract]   [Full Text] [Related]  

  • 2. [Particle size determination in suspension and emulsion ointments. The modern status of pharmacopoeia requirements].
    Stejskalová E; Safarík L
    Cesk Farm; 1981 Feb; 30(1):21-5. PubMed ID: 7237584
    [No Abstract]   [Full Text] [Related]  

  • 3. Fine particle adsorption to glass vials.
    Runkel RA; Palagyi L
    Bull Parenter Drug Assoc; 1972; 26(3):114-28. PubMed ID: 5035116
    [No Abstract]   [Full Text] [Related]  

  • 4. Micronization in pharmaceutics and in specifications of pharmacopoeas.
    Setnikar I
    Boll Chim Farm; 1977 Jul; 116(7):393-401. PubMed ID: 901645
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G; Vanderbist F; Amighi K
    Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on particle size problems. VI. Fundamentals on pharmacopoeial control of particle size in the sub-sieve range.
    Moller N
    Dan Tidsskr Farm; 1970; 44(9):348-57. PubMed ID: 5485811
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sedimentation and sedimentation retarders, especially celluloses, with a pharmacopoeia proposal "cellulose powder"].
    Graf E; Graser M; Walker R
    Arch Pharm Ber Dtsch Pharm Ges; 1971 Mar; 304(3):61-84. PubMed ID: 4946886
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
    Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily mortality and fine and ultrafine particles in Erfurt, Germany part I: role of particle number and particle mass.
    Wichmann HE; Spix C; Tuch T; Wölke G; Peters A; Heinrich J; Kreyling WG; Heyder J
    Res Rep Health Eff Inst; 2000 Nov; (98):5-86; discussion 87-94. PubMed ID: 11918089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Techology of pharmaceutical powders: granulometric tests of powders].
    Castoldi B; Folisi V; Fontani F; Rocchi I; Sekules G; Zanotti-gerosa A
    Boll Chim Farm; 1977 Jan; 116(1):2-14. PubMed ID: 851506
    [No Abstract]   [Full Text] [Related]  

  • 11. [Volume increase coefficients for solutions and suspensions of several pharmaceutical substances].
    Bondarenko GI; Osipovich AP
    Farm Zh; 1978; (4):62-4. PubMed ID: 689159
    [No Abstract]   [Full Text] [Related]  

  • 12. [System and symbols of coarse pharmaceutical dispersions].
    Melichar M
    Cesk Farm; 1974 May; 23(4):132-8. PubMed ID: 4830772
    [No Abstract]   [Full Text] [Related]  

  • 13. [Technology of pharmaceutic powders: dry and humid granulation].
    Cristoferi A; Fumagalli A; Merlini A; Vernier A
    Boll Chim Farm; 1976 Sep; 115(9):625-37. PubMed ID: 1016617
    [No Abstract]   [Full Text] [Related]  

  • 14. Extemporaneous preparation of suppositories and divided powders.
    Sandell E
    Acta Pharm Suec; 1977; 14(5-6):525-8. PubMed ID: 596168
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimisation of powders for pulmonary delivery using supercritical fluid technology.
    Rehman M; Shekunov BY; York P; Lechuga-Ballesteros D; Miller DP; Tan T; Colthorpe P
    Eur J Pharm Sci; 2004 May; 22(1):1-17. PubMed ID: 15113578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel approach towards predicting the milling behaviour of pharmaceutical powders.
    Kwan CC; Chen YQ; Ding YL; Papadopoulos DG; Bentham AC; Ghadiri M
    Eur J Pharm Sci; 2004 Dec; 23(4-5):327-36. PubMed ID: 15567285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technology of pharmaceutic powders: tablets produced using a special technology].
    Arecco D; Bassi M; Gabrielli B; Merlini A
    Boll Chim Farm; 1976 Oct; 115(10):680-701. PubMed ID: 1016598
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on flow properties of powders. V. Shear cell measurements of crystalline and spray dried lactose.
    Kristensen HG
    Dan Tidsskr Farm; 1971; 45(3):64-72. PubMed ID: 5575283
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of permeametry and photometry for the measurement of surface area of powders.
    Nyström C; Malmqvist K; Alex W
    Acta Pharm Suec; 1977; 14(5-6):497-504. PubMed ID: 596166
    [No Abstract]   [Full Text] [Related]  

  • 20. Particle size analysis of some pharmaceutical suspensions, measured by the pipette method of Andreasen.
    Joos P; Ruyssen R; Hamers Y
    J Pharm Belg; 1970; 25(2):133-51. PubMed ID: 5515737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.